Division of Terumo Corp.
Latest From MicroVention Inc.
The Woven EndoBridge (WEB) aneurysm embolization system proved relatively safe and effective in the 150-patient WEB-IT trial. The trial results are now published in the Journal of Neurointerventional Surgery.
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. Terumo and Cook each nabbed US FDA approvals for endovascular devices.
US FDA has issued new guidelines to providers because some patients experienced strokes or died after being treated for unruptured brain aneurysms with some neurovascular stents.
Terumo will pay up to $380m for privately-held Sequent Medical to and improve its presence in the US neurovascular device market with Sequent’s WEB embolization system for treatment of wide-neck bifurcation intracranial aneurysms, the Japanese medtech giant announced on June 16.
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Therapeutic Areas
- Neurology, Nervous System > Stroke
- North America
- Parent & Subsidiaries
- Terumo Corp.
- Senior Management
Michael Kleine, Pres. & CEO
Richard Cappetta, VP, Worldwide Sales & Mktg.
Robert Rosenbluth, Chmn.
- Contact Info
Phone: (949) 768-1184
Aliso Viejo, CA 92656
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.